SURBHI UDESHI: Open Payments
NPI 1801301718 · MONTCLAIR, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$379 in 15 payments from 6 companies in 2025. Trend: 2023 $689 · 2024 $510 · 2025 $379
Food & beverage: $379
| Company | Payments | Amount |
|---|---|---|
| Grifols USA, LLC | 4 | $104 |
| GlaxoSmithKline, LLC. | 4 | $96 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $87 |
| Verona Pharma, Inc. | 2 | $51 |
| UCB, Inc. | 1 | $28 |
| ABBVIE INC. | 1 | $14 |
Products named: Prolastin-C Liquid, TRELEGY ELLIPTA, OFEV, Ohtuvayre, Nayzilam, JASCAYD, NUCALA, AVYCAZ.
Industry payments across CA — which companies pay providers there.
